NRSN logo

NeuroSense Therapeutics Ltd. (NRSN)

Profile

Full Name

NeuroSense Therapeutics Ltd.

Ticker

NASDAQ: NRSN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Israel

IPO

December 9, 2021

Indexes

Not included

Website

https://www.neurosense-tx.com

Employees

17

Key Details

Price

$1.25(1.63%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$0.55(25.92% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.25
    NRSN price is $1.25

    30-Day Relative Volume

    0.22
    NRSN 30-day relative volume is 0.22

    Price Performance

    Price Most Recent Change

    +1.63%
    NRSN price was up +1.63% on Oct 3, 2025

    Price YTD Change

    +4.17%
    NRSN price is up +4.17% since January 1st

    Price 1-Year Change

    -0.79%
    NRSN price is down -0.79% year-on-year

    Price 3-Year Change

    -26.9%
    NRSN price is down -26.9% over the past 3 years

    Price Range

    Price All-Time High

    $8.18
    NRSN price is currently -84.72% below its historical high of $8.18

    Price 3-Year Low

    $0.40
    NRSN price is currently +212.50% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $30.75M
    NRSN market cap is $30.75 million

    Market Cap 3-Year Change

    +52.64%
    NRSN market cap is up +52.64% over the past 3 years

    Market Cap All-Time High

    $68.18M
    NRSN market cap is currently -54.89% below its historical high of $68.18 million

    Market Cap Sector Percentile

    26.6%
    NRSN market cap is higher than 26.6% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +24.2%
    NRSN shares outstanding is up +24.2% year-on-year

    Shares Outstanding 3-Year Change

    +108.81%
    NRSN shares outstanding is up +108.81% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.48
    NRSN beta is 0.48

    200-day SMA

    $1.33
    NRSN price is currently -6.32% below its 200-day simple moving average

    50-day SMA

    $1.27
    NRSN price is currently -1.24% below its 50-day simple moving average

    14-Day RSI

    51.01
    NRSN 14-day relative strength index is 51.01

    Volume

    0.22
    NRSN 30-day relative volume is 0.22

    ATR

    $0.10
    NRSN average true range is $0.10

    10-day Historical Volatility

    45.22%
    NRSN 10-day historical volatility is 45.22%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    NRSN annual revenue is $0.00

    Revenue Analysts Estimate

    -
    NRSN annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    NRSN annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.74%
    NRSN annual revenue is higher than 28.74% of companies in Healthcare sector

    EPS

    EPS

    -$0.55
    NRSN annual earnings per share is -$0.55

    EPS Analysts Estimate

    -$0.40
    NRSN annual earnings per share is currently +37.23% higher than the consensus analysts' forecast

    EPS 1-Year Change

    +25.92%
    NRSN annual earnings per share is up +25.92% year-on-year

    EPS Sector Percentile

    65.57%
    NRSN annual earnings per share is higher than 65.57% of companies in Healthcare sector

    Profit

    Gross Profit

    -$22.00K
    NRSN annual gross profit is -$22.00 thousand

    Gross Margin

    -
    NRSN annual gross profit margin value is unknown

    Operating Profit

    -$9.90M
    NRSN annual operating income is -$9.90 million

    Operating Margin

    -
    NRSN annual operating profit margin value is unknown

    Net Income

    -$10.21M
    NRSN annual net profit is -$10.21 million

    Net Margin

    -
    NRSN annual net profit margin value is unknown

    Expenses

    Total Expenses

    $9.90M
    NRSN annual total expenses is $9.90 million

    Operating Expenses

    $9.90M
    NRSN annual total operating expenses is $9.90 million

    Cost Of Goods Sold

    $22.00K
    NRSN annual cost of goods sold is $22.00 thousand

    Selling, General & Administrative Expenses

    $4.20M
    NRSN annual SG&A is $4.20 million

    Depreciation & Amortization

    $22.00K
    NRSN annual D&A is $22.00 thousand

    Interest Expense

    $0.00
    NRSN annual interest expense is $0.00

    Income Tax

    $0.00
    NRSN annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$9.90M
    NRSN annual earnings before interest & taxes is -$9.90 million

    EBITDA

    -$9.88M
    NRSN annual EBITDA is -$9.88 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $4.58M
    NRSN annual total assets is $4.58 million

    Non Current Assets

    $173.00K
    NRSN annual long term assets is $173.00 thousand

    Current Assets

    $4.40M
    NRSN annual total current assets is $4.40 million

    Cash and Cash Equivalents

    $3.38M
    NRSN annual cash & cash equivalents is $3.38 million

    Accounts Receivable

    -
    NRSN annual accounts receivable value is unknown

    Inventory

    $0.00
    NRSN annual inventory is $0.00

    Liabilities

    Total Liabilities

    $1.99M
    NRSN annual total liabilities is $1.99 million

    Long Term Liabilities

    $0.00
    NRSN annual total long term liabilities is $0.00

    Current Liabilities

    $1.99M
    NRSN annual current liabilities is $1.99 million

    Accounts Payable

    $1.16M
    NRSN annual accounts payable is $1.16 million

    Debt

    Total Debt

    $73.00K
    NRSN annual total debt is $73.00 thousand

    Total Debt 1-Year Change

    -48.59%
    NRSN annual total debt is down -48.59% year-on-year

    Long Term Debt

    $0.00
    NRSN annual long term debt is $0.00

    Short Term Debt

    $73.00K
    NRSN annual short term debt is $73.00 thousand

    Equity & Capital

    Shareholders Equity

    $2.58M
    NRSN annual stockholders equity is $2.58 million

    Book Value

    $2.58M
    NRSN annual book value is $2.58 million

    Retained Earnings

    -$36.66M
    NRSN annual retained earnings is -$36.66 million

    Working Capital

    $2.41M
    NRSN annual working capital is $2.41 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$10.13M
    NRSN annual cash from operations is -$10.13 million

    Cash From Operations 1-Year Change

    -21.32%
    NRSN annual cash from operations is down -21.32% year-on-year

    Cash From Investing

    $1000.00
    NRSN annual cash from investing is $1000.00

    Cash From Investing 1-Year Change

    -99.97%
    NRSN annual cash from investing is down -99.97% year-on-year

    Cash From Financing

    $10.91M
    NRSN annual cash from financing is $10.91 million

    Cash From Financing 1-Year Change

    +174.54%
    NRSN annual cash from financing is up +174.54% year-on-year

    CAPEX

    CAPEX

    $3000.00
    NRSN annual capital expenditures is $3000.00

    CAPEX 1-Year Change

    -89.66%
    NRSN annual capital expenditures is down -89.66% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$10.14M
    NRSN annual free cash flow is -$10.14 million

    Free Cash Flow 1-Year Change

    -20.94%
    NRSN annual free cash flow is down -20.94% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    NRSN annual gross profit margin value is unknown

    Operating Margin

    -
    NRSN annual operating profit margin value is unknown

    Net Margin

    -
    NRSN annual net profit margin value is unknown

    ROA & ROE

    ROA

    -263.14%
    NRSN annual return on assets is -263.14%

    ROE

    -2478.16%
    NRSN annual return on equity is -2478.16%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    NRSN price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    NRSN price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    -59.25
    NRSN price to book ratio is -59.25

    PB Ratio Sector Percentile

    1.6%
    NRSN price to book ratio is higher than 1.6% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    NRSN price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    NRSN price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    -
    NRSN enterprise value value is unknown

    Enterprise Value Sector Percentile

    -
    NRSN enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    NRSN EV/EBITDA value is unknown

    EV/EBITDA Sector Percentile

    -
    NRSN EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    2.21
    NRSN annual current ratio is 2.21

    Quick Ratio

    2.21
    NRSN annual quick ratio is 2.21

    Leverage

    Debt To Equity

    0.03
    NRSN annual debt to equity ratio is 0.03

    Interest Coverage Ratio

    -
    NRSN annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    NRSN piotroski f-score value is unknown

    Altman Z-Score

    -8.47
    NRSN altman z-score is -8.47

    Analyst ratings

    Recent major analysts updates

    Aug 15, 25 D. Boral Capital
    Buy
    Jul 10, 25 D. Boral Capital
    Buy
    May 12, 25 D. Boral Capital
    Buy
    Dec 16, 24 Maxim Group
    Hold

    Institutional Ownership

    Screeners with NRSN included

    Growing Shares Outstanding
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for NeuroSense Therapeutics Ltd.?
    • Does NeuroSense Therapeutics Ltd. pay dividends?
    • What sector is NeuroSense Therapeutics Ltd. in?
    • What industry is NeuroSense Therapeutics Ltd. in?
    • What country is NeuroSense Therapeutics Ltd. based in?
    • When did NeuroSense Therapeutics Ltd. go public?
    • Is NeuroSense Therapeutics Ltd. in the S&P 500?
    • Is NeuroSense Therapeutics Ltd. in the NASDAQ 100?
    • Is NeuroSense Therapeutics Ltd. in the Dow Jones?
    • When was NeuroSense Therapeutics Ltd.'s last earnings report?
    • When does NeuroSense Therapeutics Ltd. report earnings?

    What is the ticker symbol for NeuroSense Therapeutics Ltd.?

    The ticker symbol for NeuroSense Therapeutics Ltd. is NASDAQ:NRSN

    Does NeuroSense Therapeutics Ltd. pay dividends?

    No, NeuroSense Therapeutics Ltd. does not pay dividends

    What sector is NeuroSense Therapeutics Ltd. in?

    NeuroSense Therapeutics Ltd. is in the Healthcare sector

    What industry is NeuroSense Therapeutics Ltd. in?

    NeuroSense Therapeutics Ltd. is in the Biotechnology industry

    What country is NeuroSense Therapeutics Ltd. based in?

    NeuroSense Therapeutics Ltd. is headquartered in Israel

    When did NeuroSense Therapeutics Ltd. go public?

    NeuroSense Therapeutics Ltd.'s initial public offering (IPO) was on December 9, 2021

    Is NeuroSense Therapeutics Ltd. in the S&P 500?

    No, NeuroSense Therapeutics Ltd. is not included in the S&P 500 index

    Is NeuroSense Therapeutics Ltd. in the NASDAQ 100?

    No, NeuroSense Therapeutics Ltd. is not included in the NASDAQ 100 index

    Is NeuroSense Therapeutics Ltd. in the Dow Jones?

    No, NeuroSense Therapeutics Ltd. is not included in the Dow Jones index

    When was NeuroSense Therapeutics Ltd.'s last earnings report?

    NeuroSense Therapeutics Ltd.'s most recent earnings report was on March 22, 2023

    When does NeuroSense Therapeutics Ltd. report earnings?

    The date for NeuroSense Therapeutics Ltd.'s next earnings report has not been announced yet
    On this page